TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · no major macro event
KRYS

Krystal Biotech Inc

Healthcare · Biotechnology

345.80$ +0.2% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Cash Flow

All figures as a percentage of revenue in the same period.

Tick rows to compare them in a chart (up to 4)

Cash Flow KRYS
Line item 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
– – -919.7% – – – – -175.2% 42.5% 51.6%
– – 13.7% – – – – 9.9% 2.3% 1.7%
– – 77.1% – – – – 78.8% 16.9% 14.0%
– – 77.1% – – – – – – –
– – 49.8% – – – – -74.7% -5.0% -9.4%
– – 217.5% – – – – 23.3% 1.5% 3.1%
– – -1,005.2% – – – – 163.0% -56.3% -15.0%
– – 7,190.6% – – – – – – –
– – 7,190.6% – – – – 399.9% 9.3% 2.2%
– – 5,265.7% – – – – 387.4% -4.6% 38.9%
– – -1,137.2% – – – – -198.4% 41.0% 48.5%

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?